An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Hypothalamic Injury

Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome

NCT02179151 ·Status: TERMINATED ·Phase: PHASE3

Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or Obese

NCT06445075 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity

NCT06046443 ·Status: COMPLETED ·Phase: PHASE2

Aleniglipron Phase 2 Body Composition Study

NCT07169942 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study in People With Obesity to Test the Effects of BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the Liver

NCT05202353 ·Status: RECRUITING ·Phase: PHASE1

A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants Receiving a Glucagon-like Peptide-1 (GLP-1) Agonist

NCT06500429 ·Status: COMPLETED ·Phase: PHASE2

The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study

NCT06217848 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Effects of the GLP-1 Exenatide on Satiety in Lean and Obese Women

NCT01501084 ·Status: COMPLETED ·Phase: PHASE1

A Research Study on How NNC0487-0111 Works in People With Overweight or Obesity

NCT05369390 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of Gastric Content of Volunteers Fasting and Using Semaglutide: an Observational and Cross-sectional Study

NCT06154486 ·Status: COMPLETED

A Study in People With Overweight or Obesity to Test How Well Different Doses of BI 1820237 Are Tolerated When Given Alone or in Combination With Either Semaglutide or BI 456906

NCT05751226 ·Status: COMPLETED ·Phase: PHASE1

A Study to Investigate Weight Management With LY3549492 Compared With Placebo in Adult Participants With Obesity or Overweight

NCT06683508 ·Status: COMPLETED ·Phase: PHASE2

A Research Study of How NNC0174-0833 Taken With Semaglutide Works in People Who Are Overweight or Obese

NCT03600480 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese

NCT05616013 ·Status: COMPLETED ·Phase: PHASE2

A Research Study Investigating NNC0247-0829 for Weight Management in People With Overweight or Obesity

NCT04010786 ·Status: COMPLETED ·Phase: PHASE1

Open-Label Study of Setmelanotide in Hypothalamic Obesity

NCT04725240 ·Status: COMPLETED ·Phase: PHASE2

Setmelanotide in a Single Patient With Partial Lipodystrophy

NCT03262610 ·Status: COMPLETED ·Phase: PHASE2

Effects of Long-Acting GLP-1 (Glucagon-like Peptide-1) or Dual Incretin (GLP-1 and GIP [Glucose-dependent Insulinotropic Peptide]) Modulation on Gastric Motor Functions

NCT06801015 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

A Two-Part First-In-Human Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GUB014295

NCT06144684 ·Status: COMPLETED ·Phase: PHASE1

Inhibition of Food Intake in Response to Oral GLP-1 and Peptide YY3-36

NCT00822705 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Long-Term Study To Examine The Effects Of CP-945,598 On Weight Loss And Safety

NCT00375401 ·Status: TERMINATED ·Phase: PHASE3

Study to Evaluate the Effect on Obesity of QW Nimacimab and QW Nimacimab Co-administered With Semaglutide vs Placebo

NCT06577090 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Safety, Tolerability and Pharmacokinetics of Multiple Doses of ZGN-433 in Obese Female Volunteers

NCT01028261 ·Status: COMPLETED ·Phase: PHASE1

GLP-1 Analogue Effects on Food Cues, Stress, Motivation for Highly Palatable Foods, and Weight

NCT04779697 ·Status: COMPLETED ·Phase: PHASE1

A Study of TG103 Injection in Overweight or Obesity

NCT05299697 ·Status: UNKNOWN ·Phase: PHASE2